J&J says its single-shot COVID vaccine shows strong activity against Delta

Reuters2021-07-02

July 1 (Reuters) - Johnson & Johnson said late Thursday that its single-shot COVID-19 vaccine generated strong, persistent activity against the Delta variant, and other highly prevalent variants.

Data showed that the durability of the immune response lasted through at least eight months, the company said.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
9